NASDAQ · Biotechnology

Crispr Therapeutics AG (CRSP)

$59.50 +2.37%

Add alert

67 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$53.49+11.24%

Company profile

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.

SectorHealthcare

IndustryBiotechnology

Market cap$5.17B

P/E ratioNone

EPS$-4.71

Beta1.738

Dividend yield0.00%

52-week high$78.48

52-week low$44.12

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 79 VRTX Vertex Pharmaceuticals Inc RSI 67 IOVA Iovance Biotherapeutics Inc RSI 72 MRNA Moderna Inc RSI 72 VKTX Viking Therapeutics Inc RSI 48 SRPT Sarepta Therapeutics Inc RSI 59 EDIT Editas Medicine Inc RSI 57 NVAX Novavax Inc RSI 63 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 46 RXRX Recursion Pharmaceuticals Inc - Class A RSI 59

Free forever

RSI alerts for CRSP

Get an email the moment Crispr Therapeutics AG crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 3:30 AM EDT